Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 21, 2022; 10(3): 856-869
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.856
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.856
Figure 2 Representative hematoxylin and eosin images of the three immune subtypes (200 ×).
A and B: Tumors with high infiltrating lymphocytes in the tumor center, invasive front and peritumor (Immunehigh) subtype; C and D: Tumors other than immunehigh and immunelow (Immunemod) subtype; E and F: Tumors with low infiltrating lymphocytes in the tumor center, invasive front and peritumor (Immunelow) subtype; A, C, and E: Immune cells in tumor center; B, D, and F: Immune cells in the peritumor region.
- Citation: Du M, Cai YM, Yin YL, Xiao L, Ji Y. Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections. World J Clin Cases 2022; 10(3): 856-869
- URL: https://www.wjgnet.com/2307-8960/full/v10/i3/856.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i3.856